'Luteal coasting' after GnRH agonist trigger - Individualized, HCG-based, progesterone-free luteal support in 'high responders': A case series

Reproductive BioMedicine Online

Volumn 31, Issue 6, 2015, Pages 747-751

  Kol, Shahar ^a   Breyzman, Tatiana ^a   Segal, Linoy ^b   Humaidan, Peter ^c,d  

^a IVF Unit   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c SKIVE REGIONAL HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

GnRHa trigger; HCG; luteal coasting; luteal support; ovarian hyperstimulation syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; PROGESTERONE; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; FOLLICULAR PHASE; HIGH RISK PATIENT; HUMAN; LIVE BIRTH; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; LUTEOLYSIS; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFECTS; IN VITRO FERTILIZATION; MALE; OVULATION INDUCTION; PERSONALIZED MEDICINE; PREGNANCY; PROCEDURES; YOUNG ADULT;

ADULT; CHORIONIC GONADOTROPIN; COHORT STUDIES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEAL PHASE; MALE; OOCYTE RETRIEVAL; OVULATION INDUCTION; PRECISION MEDICINE; PREGNANCY; PROGESTERONE; YOUNG ADULT;

EID: 84951111902     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2015.09.001     Document Type: Article

References (21)

1. R. Abdallah, I. Kligman, O. Davis, and Z. Rosenwaks Withholding gonadotropins until human chorionic gonadotropin administration Semin. Reprod. Med 28 2010 486 492
2. V.L. Baker, C.A. Jones, K. Doody, R. Foulk, B. Yee, G.D. Adamson, B. Cometti, G. DeVane, G. Hubert, S. Trevisan, F. Hoehler, C. Jones, and M. Soules A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization Hum. Reprod 29 2014 2212 2220
3. A. Delvigne, and S. Rozenberg Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review Hum. Reprod. Update 8 2002 559 577
4. P. Devroey, N.P. Polyzos, and C. Blockeel An OHSS-Free Clinic by segmentation of IVF treatment Hum. Reprod 26 2011 2593 2597
5. H.M. Fatemi, N.P. Polyzos, I. van Vaerenbergh, C. Bourgain, C. Blockeel, B. Alsbjerg, E.G. Papanikolaou, and P. Humaidan Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil. Steril 100 2013 742 747
6. H.M. Fatemi, B. Popovic-Todorovic, P. Humaidan, S. Kol, M. Banker, P. Devroey, and J.A. García-Velasco Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol Fertil. Steril 101 2014 1008 1011
7. D. Griffin, C. Benadiva, N. Kummer, T. Budinetz, J. Nulsen, and L. Engmann Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders Fertil. Steril 97 2012 1316 1320
8. A.S. Gurbuz, F. Gode, N. Ozcimen, and A.Z. Isik Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases Reprod. Biomed. Online 29 2014 541 544
9. J. Haas, A. Kedem, R. Machtinger, S. Dar, A. Hourvitz, G. Yerushalmi, and R. Orvieto HCG (1500 IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels-a proof of concept J Ovarian Res 7 2014 35
10. M.G. Hull, P.E. Savage, D.R. Bromham, A.A. Ismail, and A.F. Morris The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles Fertil. Steril 37 1982 355 360
11. P. Humaidan, and B. Alsbjerg GnRHa trigger for final oocyte maturation: is HCG trigger history? Reprod. Biomed. Online 29 2014 274 280
12. P. Humaidan, and N.P. Polyzos Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology-'The king is dead, long live the king! Fertil. Steril 102 2014 339 341
13. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grøndahl, L. Westergaard, and C.Y. Andersen GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum. Reprod 20 2005 1213 1220
14. P. Humaidan, N.P. Polyzos, B. Alsbjerg, K. Erb, A.L. Mikkelsen, H.O. Elbaek, E.G. Papanikolaou, and C.Y. Andersen GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients Hum. Reprod 28 2013 2511 2521
15. IVF Worldwide Survey on vitrification, GnRH trigger and differed embryo transfer http://www.ivf-worldwide.com/survey/vitrification-gnrhtrigger-and-differed-et.html 2013 accessed 11.12.13
16. S. Kol, P. Humaidan, and J. Itskovitz-Eldor GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study Hum. Reprod 26 2011 2874 2877
17. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, K. Diedrich, and G. Griesinger A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum. Reprod 20 2005 2887 2889
18. A. Seyhan, B. Ata, M. Polat, W.Y. Son, H. Yarali, and M.H. Dahan Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG Hum. Reprod 28 2013 2522 2528
19. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil. Steril 95 2011 2715 2717
20. J. Tesarik, A. Hazout, and C. Mendoza Luteinizing hormone affects uterine receptivity independently of ovarian function Reprod. Biomed. Online 7 2003 59 64
21. J.L. Yovich, D.L. Willcox, J.G. Grudzinskas, and A.E. Bolton The prognostic value of HCG, PAPP-A, oestradiol-17 beta and progesterone in early human pregnancy Aust. N. Z. J. Obstet. Gynaecol 26 1986 59 64